Key result
Transthoracic echocardiography identified 98.6% of superior pulmonary veins and yielded diameter measurements comparable to computed tomography before atrial fibrillation ablation.
Why the study?
No study had focused on the role of transthoracic echocardiography in evaluating the diameter and anatomy of pulmonary veins for atrial fibrillation ablation.
Does transthoracic echocardiography accurately measure pulmonary vein diameter and anatomy compared to computed tomography in patients with atrial fibrillation undergoing catheter ablation?
Observational (n=142)
Blinded assessors
No
Does transthoracic echocardiography accurately measure pulmonary vein diameter and anatomy compared to computed tomography in patients with atrial fibrillation undergoing catheter ablation?
Answers are grounded in this paper and cite their sources.
Transthoracic echocardiography is a feasible, non-invasive alternative to CT for measuring pulmonary vein diameters before atrial fibrillation ablation, though it is less reliable for identifying complex anatomic variations.
BACKGROUND: Transesophageal echocardiography may be used to assess pulmonary veins for atrial fibrillation ablation. No study focused on the role of transthoracic echocardiography (TTE) in evaluating the diameter and anatomy of pulmonary veins. METHODS: Among 142 atrial fibrillation patients (57.7% men; mean age, 60.5) hospitalised for catheter ablation, we assessed pulmonary veins and compared the measurements by TTE with cardiac computed tomography (CT) before ablation. Among 17 patients who had follow-up examinations, the second measurements were also studied. RESULTS: TTE identified and determined the diameters of 140 (98.6%) right and 140 (98.6%) left superior PVs, and 136 (95.7%) right and 135 (95.1%) left inferior PVs. A separate middle PV ostia was identified in 14 out of the 22 patients (63.6%) for the right side and in 2 out of 4 (50.0%) for the left side. The PV diameters before ablation assessed by CT vs. TTE were 17.96 vs. 18.07 mm for right superior, 15.92 vs. 15.51 mm for right inferior, 18.54 vs. 18.42 mm for left superior, and 15.56 vs. 15.45 mm for left inferior vein. The paired differences between the assessments of CT and TTE were not significant (P ≥ 0.31) except for the right inferior vein with a CT-minus-TTE difference of 0.41 mm (P = 0.018). The follow-up PV diameters by both CT (P ≥ 0.069) and TTE (P ≥ 0.093) were not different from baseline measurements in the 17 patients who had follow-up measurements. CONCLUSIONS: With a better understanding of PV anatomy in TTE imaging, assessing PV diameters by non-invasive TTE is feasible. However, the clear identification of anatomic variation might still be challenging.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2019) conducted an observational in Atrial fibrillation (n=142). Transthoracic echocardiography (TTE) vs. Computed tomography (CT) was evaluated on Right superior pulmonary vein diameter (mm) (p=0.45). Transthoracic echocardiography identified 98.6% of superior pulmonary veins and yielded diameter measurements comparable to computed tomography before atrial fibrillation ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: